Aytu Biopharma (AYTU) FCF Margin Growth (3y) (2017 - 2026)
Aytu Biopharma (AYTU) FCF Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 213.00 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 2,102.00 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 180.00 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 1,592.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -291.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -2,476.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 1,604.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Aytu Biopharma | 24.81 Mn | -1.91 Mn | 7.60 Mn | -2,094.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,089.00 |
| Dec 31, 2025 | 3,359.00 |
| Sep 30, 2025 | 2,846.00 |
| Jun 30, 2025 | 4,426.00 |
| Mar 31, 2025 | 231.00 |
| Dec 31, 2024 | 5,598.00 |
| Sep 30, 2024 | 935.00 |
| Jun 30, 2024 | -3,643.00 |
| Dec 31, 2023 | 1,847.00 |
| Sep 30, 2023 | 5,799.00 |
| Jun 30, 2023 | 4,355.00 |
| Mar 31, 2023 | -24,883.00 |
| Dec 31, 2022 | 32,437.00 |
| Sep 30, 2022 | 17,461.00 |
| Jun 30, 2022 | 20,228.00 |
| Mar 31, 2022 | 7,042.00 |
| Dec 31, 2021 | 24,582.00 |
| Sep 30, 2021 | 17,475.00 |
| Jun 30, 2021 | 51,989.00 |
| Dec 31, 2020 | 27,582.00 |